Shorter TB treatment: a 4-Month regimen put to the test
NCT ID NCT06727864
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This trial is testing whether a 4-month treatment for drug-sensitive pulmonary tuberculosis works as well as the standard 6-month regimen. The study involves 270 adults with newly diagnosed TB. If the shorter course proves effective, it could make treatment easier to complete and help reduce the spread of TB.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A 4-month anti-tuberculosis drug regimen (2HERZ/2HRE) compared to the standard 6-month regimen (2HERZ/4HRE)
- What this could lead to
- If successful, this could shorten TB treatment to 4 months, improving completion rates and reducing transmission.
- What could go wrong
- The shorter regimen may be less effective or have more side effects than the standard 6-month course. Results are not yet available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
E-DA Healthcare Group
RECRUITINGKaohsiung City, Yanchao, 82445, Taiwan
-
Far Eastern Memorial Hospital
RECRUITINGNew Taipei City, Bangiao, 220, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITINGKaohsiung City, 80756, Taiwan
-
Kaohsiung Veterans General Hospital
RECRUITINGKaohsiung City, 813, Taiwan
-
Linkou Chang Gung Memorial Hospital
RECRUITINGTaoyuan City, 333, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, Taiwan
-
Taichung Hospital
RECRUITINGTaichung, West, 199, Taiwan
-
Taipei Veterans General Hospital
RECRUITINGTaipei, 112, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new patient cohort unlock the secrets of TB treatment success?
- Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
- Can a more powerful antibiotic clear TB faster? a trial puts rifapentine to the test.
- Could a simple screening strategy uncover hidden TB in COPD patients?
- Talking it out: could counseling be the key to beating TB?
- New TB vaccine aims to prevent active lung disease in adults